| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
6 companies
Clark Ian T is a Director at Olema Pharmaceuticals, Inc. with holdings across 6 companies. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $6.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | OLMA Olema Pharmaceuticals, Inc. | Director | Sale+OE | 264,800 | $29.73 | $7,873,109.28 | -48.9% | -46.4% | - | |
| Dec 5, 2025 | GH Guardant Health, Inc. | Director | Sale+OE | 28,611 | $107.19 | $3,066,817.22 | -34.9% | -9.3% | - | |
| Jun 17, 2025 | GH Guardant Health, Inc. | Director | Sell | 6,672 | $48.38 | $322,818.72 | -40.4% | +10.6% | - | |
| Nov 12, 2024 | GH Guardant Health, Inc. | Director | Sale+OE | 8,318 | $29.45 | $244,929.50 | -25.6% | +49.3% | +229.1% | |
| Sep 1, 2021 | GH Guardant Health, Inc. | Director | Sale+OE | 1,076 | $130.00 | $139,880.00 | -100% | -20.1% | -62.7% | |
| Jun 29, 2021 | GH Guardant Health, Inc. | Director | Sale+OE | 10,559 | $130.00 | $1,372,670.00 | -100% | -1.6% | -67.1% | |
| Apr 26, 2021 | GH Guardant Health, Inc. | Director | Sale+OE | 538 | $159.92 | $86,036.96 | -10.4% | -32.5% | -60.1% | |
| Mar 25, 2021 | GH Guardant Health, Inc. | Director | Sale+OE | 538 | $132.09 | $71,064.42 | -10.4% | -5.1% | -55.9% | |
| Feb 25, 2021 | GH Guardant Health, Inc. | Director | Sale+OE | 538 | $154.00 | $82,852.00 | -10.4% | - | - | |
| Jan 25, 2021 | GH Guardant Health, Inc. | Director | Sale+OE | 538 | $162.00 | $87,156.00 | -10.4% | - | - |